Novo Nordisk ADR
Novo Nordisk ADR (NVO) Historical Volatility
NVO 30-day historical volatility is 38%. This ranks in the 53th percentile of readings over the past year.
Read more
Tracking NVO historical volatility helps you see how much Novo Nordisk ADR's stock price has actually moved over past periods, giving you a baseline to judge whether current option premiums are fair, cheap, or expensive. While implied volatility tells you what the market expects, Novo Nordisk ADR's HV tells you what really happened. Use our scanner to monitor NVO 30 day historical volatility alongside longer lookback windows and spot the moments when realized and implied diverge.
Historical volatility is the annualized standard deviation of an underlying's past returns, typically measured over rolling windows like 10, 20, 30, or 60 days. The NVO 30 day historical volatility is one of the most widely watched readings because it balances responsiveness with stability. Comparing Novo Nordisk ADR's HV to its implied volatility reveals the volatility risk premium — when IV sits well above HV, option sellers tend to have an edge; when HV runs hot relative to IV, buyers may be underpaying for movement.
Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally. It operates in two segments, Diabetes and Obesity Care, and Rare Disease. The Diabetes and Obesity care segment provides products for diabetes, obesity, cardiovascular, and other emerging therapy areas. The Rare Disease segment offers products in the areas of rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company also provides insulin pens, growth hormone pens, and injection needles.
In addition, it offers smart solutions for diabetes treatment, such as smart insulin pens and Dose Check, an insulin dose guidance application. The company has a collaboration agreement with UNICEF to tackle childhood obesity; and with Valo Health, Inc. to discover and develop novel drug programmes for cardiometabolic space. Novo Nordisk A/S was founded in 1923 and is headquartered in Bagsvaerd, Denmark.
Sizing a long premium trade, modeling a covered call, or hunting volatility arbitrage all come back to one question: how much has the stock actually moved? Our scanner puts Novo Nordisk ADR's historical volatility side-by-side with implied readings across every lookback window, so you can see exactly where NVO HV is running hot, cold, or in line. Make the NVO 30 day historical volatility — and every other window — work for your edge instead of against it.
As of September 29, 2026
As of September 29, 2026
See how volatility has moved over time
Track NVO historical volatility, spot where IV and realized volatility diverge, and find options that are priced in your favor right now.
Start your 14-day free trial→